Concepedia

Nichelle C. Whitlock

NC

11

Publications

682

Citations

11

H-Index

2007

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

National Cancer Institute

University of California, Los Angeles

University of Tennessee at Knoxville

National Institutes of Health

Nichelle C. Whitlock is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell biology, and systems biology.

Top concepts

MedicineCell BiologyInflammationCell SignalingGene ExpressionSystems BiologyOncologyApoptosisCell DeathImmunology

Publications per year

2007–2022

11

Publications

11

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart et al. · Nature Cancer · 2021 · 228 citations · Full text

Ezh2 Inhibition, Dsrna–sting–interferon Stress, Medicine +6

Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways

S-H Lee, Jae Hoon Bahn, Nichelle C. Whitlock et al. · Oncogene · 2010 · 80 citations · Full text

Inflammation, Molecular Physiology, Signal Transduction +12

Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer

S. Thomas Hennigan, Shana Y. Trostel, Nicholas T. Terrigino et al. · JCO Precision Oncology · 2019 · 73 citations · Full text

Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy

Scott Wilkinson, Huihui Ye, Fatima Karzai et al. · European Urology · 2021 · 70 citations · Full text

ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells

Seong‐Ho Lee, Jae Hoon Bahn, Chang Kyoung Choi et al. · Molecular Cancer Therapeutics · 2008 · 67 citations · Full text

Chemoprevention Strategy, Apoptosis, Immunology +21

Rows per page

1–5 of 11